Bérangère S Joly

11PUBLICATIONS
74CO-AUTHORS
Respiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyCardiology (incl. cardiovascular diseases)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 15, 2026
Natural History and Treatment Outcomes of Congenital Thrombotic Thrombocytopenic Purpura: A Retrospective Longitudinal Cohort Study.

|Aug 28, 2025
Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura.

Bérangère S Joly, Adrien Joseph, Raïda Bouzid

|Aug 08, 2025
Trp1250, Lys1252, and Arg1367 of ADAMTS13 comprise a hot spot for anti-CUB domain antibodies in patients with iTTP.

Tim Postmus, Robin Jansen, Paul Kaijen

|Jul 29, 2025
Immune-mediated thrombotic thrombocytopenic purpura with systemic lupus erythematosus: clinical features and outcome.

Júlia Weisinger, Raïda Bouzid, Jehane Fadlallah

|Jul 15, 2025
Anti-ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune-Mediated TTP.

Marie Robert, Arthur Mageau, Ygal Benhamou

|Mar 07, 2025
Thrombotic Thrombocytopenic Purpura: A Missed Cause in Stroke Prevention Guidelines.

Adrien Picod, Bérangère S Joly, Agnès Veyradier

Pageof 2

Frequent Collaborators

4 joint publications

Karen Vanhoorelbeke

3 joint publications

Paul Coppo

3 joint publications

Jan Voorberg

2 joint publications

Tim Postmus